| Formulary Chapter 9: Nutrition and blood - Full Chapter
|
| 09.01 |
Anaemias and some other blood disorders |
|
|
|
|
| 09.01.01 |
Iron-deficiency anaemias |
|
|
|
|
Ferrous Fumarate
|
Formulary
|
Ferrous Fumarate 210mg tablet
Ferrous Fumarate 140mg/5ml syrup
|
|
|
Ferrous Gluconate
|
Formulary
|
Ferrous Gluconate 300mg tablet
|
|
|
Ferrous Sulphate
|
Formulary
|
Ferrous Sulphate 200mg tablet
Ferrous Sulphate (Ferrograd) 325mg SR tablet
|
|
|
Sodium Feredetate (Sytron®)
|
Formulary
|
Sodium Feredetate (Sytron) oral liquid
|
|
|
| 09.01.01.01 |
Iron and folic acid |
|
|
| 09.01.01.01 |
Compound iron preparations |
|
|
| 09.01.01.02 |
Parenteral iron |
|
|
Ferric Carboxymaltose (Ferinject®)
|
Formulary
|
Ferric carboxymaltose (Ferinject®) 50mg/1ml injection
|
|
|
Iron Dextran (CosmoFer®)
|
Formulary
|
Iron Dextran (Cosmofer®) 100mg/2ml injection
|
|
|
Iron Isomaltoside (Monofer®)
|
Formulary
|
Iron Isomaltoside (Monofer®)
|
|
|
Iron Sucrose (Venofer®)
|
Formulary
|
Iron Sucrose (Venofer®) 100mg/5ml injection
|
|
|
| 09.01.02 |
Drugs used in megaloblastic anaemias |
|
|
Cyanocobalamin
|
Formulary
|
Cyanocobalamin 50mcg tablet
|
|
|
Folic Acid
|
Formulary
|
Folic acid 400mcg tablet
Folic acid 5mg tablet
Folic acid 2.5mg/5ml syrup
Folic acid 15mg/ml injection - unlicensed special
|
|
|
Hydroxocobalamin
(Vitamin B12)
|
Formulary
|
Hydroxocobalamin 1mg/ml injection
|
|
|
|
|
| 09.01.03 |
Drugs used in hypoplastic, haemolytic, and renal anaemias |
|
|
Hydroxycarbamide
|
Formulary
|
Hydroxycarbamide 500mg capsule
|
|
|
|
|
Darbepoetin Alfa (Aranesp®)
|
Formulary
|
Darbepoetin alpha (Aranesp®) 20mcg sureclick pen
Darbepoetin alpha (Aranesp®) 40mcg sureclick pen
Darbepoetin alpha (Aranesp®) 60mcg sureclick pen
Darbepoetin alpha (Aranesp®) 80mcg sureclick pen
Darbepoetin alpha (Aranesp®) 100mcg sureclick pen
Darbepoetin alpha (Aranesp®) 500mcg sureclick pen
For use in line with NICE TA323 (Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy)
|
 NICE TA323: Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy
|
Epoetin alfa (Eprex®)
|
Formulary
|
Epoetin alfa (Eprex®) 1,000 units/0.5ml solution for injection pre-filled syringes
Epoetin alfa (Eprex®) 2,000 units/0.5ml solution for injection pre-filled syringes
Epoetin alfa (Eprex®) 10,000 units/1ml solution for injection pre-filled syringes
Epoetin alfa (Eprex®) 3,000 units/0.3ml solution for injection pre-filled syringes
Epoetin alfa (Eprex®) 4,000 units/0.4ml solution for injection pre-filled syringes
Epoetin alfa (Eprex®) 5,000 units/0.5ml solution for injection pre-filled syringes
Epoetin alfa (Eprex®) 6,000 units/0.6ml solution for injection pre-filled syringes
Epoetin alfa (Eprex®) 8,000 units/0.8ml solution for injection pre-filled syringes
Epoetin alfa (Eprex®) 20,000 units/0.5ml solution for injection pre-filled syringes
Epoetin alfa (Eprex®) 30,000 units/0.75ml solution for injection pre-filled syringes
Epoetin alfa (Eprex®) 40,000 units/1ml solution for injection pre-filled syringes
|
|
|
Epoetin beta (NeoRecormon®)
|
Formulary
|
Epoetin beta (NeoRecoron®) 500 unit/0.3ml injection
Epoetin beta (NeoRecoron®) 1,000 unit/0.3ml injection
Epoetin beta (NeoRecoron®) 2,000 unit/0.3ml injection
Epoetin beta (NeoRecoron®) 4,000 unit/0.3ml injection
Epoetin beta (NeoRecoron®) 5,000 unit/0.3ml injection
Epoetin beta (NeoRecoron®) 6,000 unit/0.3ml injection
Epoetin beta (NeoRecoron®) 10,000 unit/0.6ml injection
Epoetin beta (NeoRecoron®) 30,000 unit/0.6ml injection
For use in line with NICE TA323 (Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy)
|
NICE TA323: Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy
|
|
|
| 09.01.03 |
Iron overload |
|
|
Deferasirox (Exjade®)
|
Formulary
|
Deferasirox (Exjade®) 90mg film coated tablet
Deferasirox (Exjade®) 180mg film coated tablet
Deferasirox (Exjade®) 360mg film coated tablet
|
|
|
Desferrioxamine Mesilate
|
Formulary
|
Desferrioxamine mesilate 500mg injection
|
|
|
| 09.01.04 |
Drugs used in autoimmune thrombocytopenic purpura |
|
|
Anagrelide (Xagrid®)
|
Formulary
|
Anagrelide (Xagrid®) 500mcg capsule
|
|
|
Eltrombopag
|
Formulary
|
Eltrombopag 25mg tablet
Eltrombopag 50mg tablet
For use in line with NICE guidance TA293 (Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic) purpura
|
NICE TA293: Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205)
|
Romiplostim (Nplate®)
|
Formulary
|
Romiplostim (Nplate®) 250mcg injection
Romiplostim (Nplate®) 500mcg injection
For use in line with NICE TA221 (Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura)
|
NICE TA221: Thrombocytopenic purpura - romiplostim
|
|
|
| 09.01.06 |
Drugs used in neutropenia |
|
|
Filgrastim
|
Formulary
|
Filgrastim 30MIU/0.5ml pre-filled syringe
Filgrastim 48MIU/0.5ml pre-filled syringe
|
|
|
Filgrastim (Ratiograstim®)
|
Formulary
|
|
|
|
Lenograstim (Granocyte®)
|
Formulary
|
Lenograstim 105mcg injection vial
Lenograstim 263mcg injection vial
|
|
|
Pegfilgrastim (Neulasta®)
|
Formulary
|
Filgrastim (as Pegfilgrastim)(Neulasta ®) 6mg/0.6ml solution for injection pre-filled syringes
|
|
|
| 09.01.07 |
Drugs used to mobilise stem cells |
|
|
| 09.02 |
Fluids and electrolytes |
|
|
| 09.02.01 |
Oral preparations for fluid and electrolyte imbalance |
|
|
Potassium chloride
|
Formulary
|
Potassium chloride 600mg SR tablet
|
|
|
| 09.02.01.01 |
Oral potassium |
|
|
Potassium Chloride (Kay-Cee-L®)
|
Formulary
|
Potassium chloride 7.5% (1mmol/ml) syrup
|
|
|
Potassium Chloride, Potassium bicarbonate (Sando-K®)
|
Formulary
|
Potassium (Sando-K®) 12mmol K+ effervescent tablet
|
|
|
| 09.02.01.01 |
Potassium removal |
|
|
Patiromer (Veltassa®)
(Veltassa)
|
Formulary
|
Patiromer (Veltassa®) 8.4g powder for oral suspension
Patiromer (Veltassa®) 16.8g powder for oral suspension
For use in line with NICE TA623 - Patiromer for treating hyperkalaemia
|
|
|
Polystyrene Sulphonate Resins (Calcium Resonium®)
|
Formulary
|
Calcium resonium powder
|
|
|
Sodium zirconium cyclosilicate powder for oral suspension (Lokelma® )
|
Formulary
|
Sodium zirconium cyclosilicate (Lokelma) 5 g powder for oral suspension
Sodium zirconium cyclosilicate (Lokelma) 10 g powder for oral suspension
For use in line with NICE TA599 Sodium zirconium cyclosilicate for treating hyperkalaemia
|
|
|
| 09.02.01.02 |
Oral sodium and water |
|
|
Sodium Chloride (Slow Sodium®)
|
Formulary
|
Sodium chloride 600mg (10mmol) SR tablet
|
|
|
| 09.02.01.02 |
Oral rehydration therapy (ORT) |
|
|
Oral Rehydration Salts (Dioralyte®)
|
Formulary
|
Dioralyte® Oral Powder Sachet (plain)
Dioralyte® Oral Powder Sachet (blackcurrant)
|
|
|
| 09.02.01.03 |
Oral bicarbonate |
|
|
Sodium Bicarbonate
|
Formulary
|
Sodium bicarbonate 600mg tablet
Sodium bicarbonate 500mg capsule
|
|
|
| 09.02.02 |
Parenteral preparations for fluid and electrolyte imbalance |
|
|
| 09.02.02.01 |
Electrolytes and water |
|
|
| 09.02.02.01 |
Intravenous sodium |
|
|
Sodium Chloride and Glucose Intravenous Infusion
|
Formulary
|
|
|
|
Sodium Chloride Intravenous
|
Formulary
|
|
|
|
| 09.02.02.01 |
Intravenous glucose |
|
|
Glucose Intravenous
|
Formulary
|
|
|
|
| 09.02.02.01 |
Intravenous potassium |
|
|
Potassium Chloride and Glucose Intravenous Infusion
|
Formulary
|
|
|
|
Potassium Chloride and Sodium Chloride Intravenous Infusion
|
Formulary
|
|
|
|
Potassium Chloride Concentrate (Sterile)
|
Formulary
|
|
|
|
Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion
|
Formulary
|
|
|
|
|
|
| 09.02.02.01 |
Bicarbonate and lactate |
|
|
Compound Sodium Lactate Intravenous Infusion
(Known as hartmanns solution)
|
Formulary
|
|
|
|
Sodium Bicarbonate
(injection)
|
Formulary
|
Sodium Bicarbonate 1.26% infusion
Sodium Bicarbonate 8.40% infusion
|
|
|
|
|
Water for Injection
|
Formulary
|
|
|
|
| 09.02.02.02 |
Plasma and plasma substitutes |
|
|
Human Albumin Solution
|
Formulary
|
|
|
|
| 09.02.02.02 |
Plasma substitutes |
|
|
Gelatin (Gelofusine®)
|
Formulary
|
|
|
|
| 09.03 |
Intravenous nutrition |
|
|
Additrace®
|
Formulary
|
Additrace® injection
|
|
|
|
|
| 09.03 |
Supplementary preparations |
|
|
|
|
|
|
| 09.04.01 |
Foods for special diets |
|
|
| 09.04.02 |
Enteral nutrition |
|
|
|
|
|
|
| 09.05.01 |
Calcium and magnesium |
|
|
| 09.05.01.01 |
Calcium supplements |
|
|
Calcichew®
(Calcium carbonate)
|
Formulary
|
Calcichew tablet
|
|
|
Calcium
|
Formulary
|
Adcal chewable tablet (600mg calcium)
|
|
|
Calcium Chloride
|
Formulary
|
Calcium chloride 5mmol/ 10ml injection
Calcium chloride 1g/10ml Mini-I-Jet injection (6.8mmol Ca in 10ml)
|
|
|
Calcium Gluconate
|
Formulary
|
Calcium gluconate 10% injection (2.2mmol Ca in 10ml)
|
 UKMI Q&A: How is acute hypermagnesaemia treated in adults?
|
Calcium syrup (Alliance)
|
Formulary
|
Calcium oral Syrup (Alliance) 102 mg/5mL
|
|
|
Sandocal
|
Formulary
|
Sandocal 400 effervescent tablet (10mmol Ca/tablet)
|
|
|
|
|
| 09.05.01.02 |
Hypercalcaemia and hypercalciuria |
|
|
Cinacalcet (Mimpara®)
|
Formulary
|
Cinacalet 30mg tablet (Mimpara®)
Cinacalet 60mg tablet (Mimpara®)
Cinacalet 90mg tablet (Mimpara®)
|
NICE TA117: Hyperparathyroidism - cinacalcet
|
| 09.05.01.03 |
Magnesium |
|
|
Magnesium Aspartate (Magnaspartate®)
|
Formulary
|
Magnesium Aspartate 243mg powder
|
|
|
Magnesium Sulphate
|
Formulary
|
Magnesium sulphate 10% (1000mg/10ml) injection
Magnesium sulphate 50% injection
|
UKMI Q&A: Can magnesium sulphate be given subcutaneously?
UKMI Q&A: Magnesium sulphate injection: converting between millimoles, milligrams and percentage w/v.
|
|
|
|
|
| 09.05.02.01 |
Phosphate supplements |
|
|
Phosphate Polyfusor®
|
Formulary
|
Phosphate polyfusor 500ml
|
|
|
Phosphate supplements (Phosphate-Sandoz®)
|
Formulary
|
Phosphate Sandoz effervescent tablet (16.1mmol phosphate, 20.4mmol sodium, 3.1mmol potassium/ tablet
|
|
|
Sodium acid phosphate
|
Formulary
|
Sodium acid phosphate oral solution
|
|
|
Sodium acid phosphate
|
 Unlicensed
|
Sodium phosphate injection (15mmol Na = 9mmol phosphate in 10ml)
|
|
|
|
|
| 09.05.02.02 |
Phosphate-binding agents |
|
|
Sevelamer Hydrochloride
|
Formulary
|
Sevelamer 800mg tablet
|
|
|
|
|
|
|
Flurides (Duraphat® (Toothpaste))
|
Formulary
|
Duraphat® toothpaste
|
|
|
Sodium Fluoride
|
Formulary
|
Sodium Fluoride 0.05% dental rinse
|
|
|
| 09.05.04 |
Zinc |
|
|
Zinc Sulphate (Solvazinc®)
|
Formulary
|
Zinc sulphate 125mg effervescent tablet (Solvazinc®)
|
|
|
|
|
Selenium
|
Formulary
|
Selenium 50 micrograms/mL injection
Selenium 50mcg/ml oral solution (Selenase®)
Selenium 100mcg/2ml injection (Selenase®)
|
|
|
|
|
|
|
|
|
Brewers Yeast Tablets
|
Formulary
|
Brewers Yeast Tablets
|
|
|
Pyridoxine Hydrochloride
|
Formulary
|
Pyridoxine 10mg tablet
Pyridoxine 50mg tablet
Pyridoxine injection 100mg in 2ml
|
|
|
Thiamine
|
Formulary
|
Thiamine 50mg tablet
Thiamine 100mg tablet
|
|
|
Vitamin B substances with ascorbic acid (Pabrinex®)
|
Formulary
|
Pabrinex® IV high potency injection
Pabrinex® IM high potency injection
|
|
|
| 09.06.02 |
Oral vitamin B complex preparations |
|
|
Vitamin B Compound Strong Tablets
|
Formulary
|
Vitamin B Compound Strong Tablet
|
|
|
|
|
|
|
Ascorbic Acid
|
Formulary
|
Acorbic acid 50mg tablet
Acorbic acid 200mg tablet
Acorbic acid 500mg tablet
Acorbic acid 1g effervescent tablet
|
|
|
|
|
Alfacalcidol
|
Formulary
|
Alfacalcidol (One-Alpha) 2mcg/ml drops
Alfacalcidol 250nanograms capsule
Alfacalcidol 1mcg capsule
Alfacalcidol 2mcg/ml injection
|
|
|
Calcitriol
|
Formulary
|
Calcitriol 250nanogram capsules
Calcitriol 500nanogram capsules
|
|
|
Colecalciferol
(Vitamin D3)
|
Formulary
|
Colecalciferol injection 300,000 units/ml
Colecalciferol oral solution 2,740 units/ml (Fultium D3®)
Colecalciferol 3,000 units/ml oral solution (unlicensed)
Colecalciferol 800 unit capsule (Desunin®)
Colecalciferol 20,000 unit capsule
|
|
|
Colecalciferol and Calcium Carbonate
|
Formulary
|
Calcium Carbonate and Colecalciferol (Adcal-D3®) dissolve 1500mg/400unit effervescent tablet
Calcium Carbonate and Colecalciferol (Adcal-D3®) 750mg/200unit caplets
Calcium Carbonate and Colecalciferol (Adcal-D3®) 1.25g/400unit chewable tablet
Calcium Carbonate and Colecalciferol (Calcichew D3®) 1.25g/200units chewable tablets
Calcium Carbonate and Colecalciferol (Calcichew D3 Forte®) 1.25g/400units chewable tablets
|
|
|
Ergocalciferol
|
Formulary
|
Ergocalciferol 3,000 units/ml liquid
Ergocalciferol 300,000 units/ml injection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alpha Tocopheryl Acetate
(Vitamin E)
|
Formulary
|
Alpha Tocopheryl Acetate 100mg chewable tablet (Imported)
Alpha Tocopheryl Acetate 500mg/5ml suspension
|
|
|
| 09.06.06 |
Vitamin K |
|
|
Menadiol Sodium Phosphate
|
Formulary
|
Menadiol sodium diphospahte 10mg tablet
|
UKMI Q&A: National guidance on vitamin K in obstetric cholestasis
|
Phytomenadione
|
Formulary
|
Phytomenadione 2mg/0.2ml solution for injection ampoules (Konakion MM Paediatric®)
Phytomenadione 10mg/ml solution for injection ampoules (Konakion MM®)
Phytomenadione capsules
|
UKMI Q&A: Guidance on the use of vitamin K for obstetric cholestasis
|
| 09.06.07 |
Multivitamin preparations |
|
|
Multivitamin preparations (Abidec®)
|
Formulary
|
Abidec® drops
|
UKMI Q&A: Abidec and peanut allergy (UKMi Q&A)
|
Multivitamin preparations (Dalivit®)
|
Formulary
|
Dalivit® drops
|
|
|
Mutivitamin (Multivitamin BPC capsule )
|
Formulary
|
Multivitamin BPC capsule
|
|
|
| 09.06.07 |
Vitamin and mineral supplements and adjuncts to synthetic diets |
|
|
Vitamin and mineral supplements (Forceval ®)
|
Formulary
|
Forceval soluble® tablets
Forceval ® capsules
|
|
|
Vitamin and mineral supplements (Ketovite®)
|
Formulary
|
Ketovite® tablets
Ketovite® liquid
|
|
|
|
|
| 09.08 |
Metabolic disorders |
|
|
| 09.08.01 |
Drugs used in metabolic disorders |
|
|
|
|
Penicillamine
|
Formulary
|
Penicillamine 125mg tablet
|
|
|
Trientene
|
Formulary
|
Trientene dihydrochloride 300mg capsules
Restricted use to consultant neurologist (Dr Pearce prescribing only)
|
|
|
| 09.08.01 |
Carnitine deficiency |
|
|
Levocarnitine (Carnitor®)
|
Formulary
|
Carnitine chewable tablet
|
|
|
|
|
| 09.08.01 |
Gaucher's disease |
|
|
| 09.08.01 |
Mucopolysaccharidosis I |
|
|
|
|
| 09.08.01 |
Nephropathic cystinosis |
|
|
| 09.08.01 |
Urea cycle disorders |
|
|
| 09.08.02 |
Acute porphyrias |
|
|
| 09.08.02 |
Drugs unsafe for use in acute porphyrias |
|
|
| .... |
| Non Formulary Items |
Babiven start up
|
Non Formulary
|
|
|
|
Cacit D3®
(Calcium carbonate)
|
Non Formulary
|
Calcium D3 Sachet (Cacit D3) |
|
|
Parenteral Nutrition (TPN or PN)
|
Non Formulary
|
|
|
|
Ringer's Solution for Injection
|
Non Formulary
|
|
|
|
| |
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Formulary |
|
Nice Approved / Formulary |
|
NICE approved |
|
Amber Restricted Use |
|
Non Formulary |
|
|
|
